Predictive Factors of Late Radiation Fibrosis: A Prospective Study in Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 38-43

  Mazeron, Renaud ^a   Etienne Mastroianni, Bénédicte ^b   Pérol, David ^a   Arpin, Dominique ^c   Vincent, Michel ^d   Falchero, Lionel ^e   Martel Lafay, Isabelle ^a   Carrie, Christian ^a   Claude, Line ^a  

^a UNIVERSITÉ DE LYON   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c CROIX ROUSSE HOSPITAL   (France)

^d CENTRE HOSPITALIER SAINT JOSEPH SAINT LUC   (France)

^e Centre Hospitalier Général   (France)

Author keywords

Cytokines; Fibrosis; Non small cell lung cancer; Predictive factors; Radiotherapy

Indexed keywords

ANTI-INFLAMMATORIES; CLINICAL EVALUATION; CONFORMAL RADIOTHERAPY; CYTOKINES; DIFFUSION PARAMETERS; DOSIMETRIC PARAMETER; FUNCTIONAL TEST; HIGHLY-CORRELATED; INTERLEUKIN-10; INTERLEUKIN-6; LATE EFFECTS; LOGISTIC REGRESSION ANALYSIS; LUNG VOLUME; MEAN LUNG DOSE; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; NORMAL TISSUE; PERFORMANCE STATUS; PREDICTIVE FACTORS; PROSPECTIVE STUDY; RADIATION FIBROSIS; RADIATION PNEUMONITIS; SERUM LEVELS; TREATMENT PARAMETERS; TUMOR GROWTH; TUMOR NECROSIS FACTORS; UNIVARIATE ANALYSIS;

BIOLOGICAL ORGANS; BIOLOGICAL RADIATION EFFECTS; DECISION MAKING; DOSIMETERS; DOSIMETRY; MULTIVARIANT ANALYSIS; REGRESSION ANALYSIS; THREE DIMENSIONAL; TUMORS;

RADIOTHERAPY;

CISPLATIN; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; COMPUTER ASSISTED RADIOTHERAPY; CYTOKINE RELEASE; DIFFUSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSIMETRY; FEMALE; HUMAN; INCIDENCE; KARNOFSKY PERFORMANCE STATUS; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION FIBROSIS; RADIATION PNEUMONIA; RADIATION SICKNESS; THORAX RADIOGRAPHY;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; KARNOFSKY PERFORMANCE STATUS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950688980     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.019     Document Type: Article

References (25)

1. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
2. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
3. Ohe Y., Yamamoto S., Suzuki K., et al. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 37 (2001) 54-63
4. Morgan G.W., and Breit S.N. Radiation and the lung: A reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 31 (1995) 361-369
5. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 41 (1998) 1029-1035
6. Chen Y., Rubin P., Williams J., et al. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49 (2001) 641-646
7. Arpin D., Perol D., Blay J.Y., et al. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis. J Clin Oncol 23 (2005) 8748-8756
8. International Commission on Radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy (Report 50). Med Phys 21 (1994) 833-834
9. Pavy J.J., Denekamp J., Letschert J., et al. EORTC Late Effects Working Group. Late effects toxicity scoring: The SOMA scale. Radiother Oncol 35 (1995) 11-15
10. Bentzen S.M., Skoczylas J.Z., and Bernier J. Quantitative clinical radiobiology of early and late lung reactions. Int J Radiat Biol 76 (2000) 453-462
11. Hartsell W.F., Scott C.B., Dundas G.S., et al. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03. Am J Clin Oncol 30 (2007) 368-376
12. Emami B., and Graham G.V. Lung. Principles and practice of radiation oncology. (3rd ed.) (1997), Lippincott-Raven, Philadelphia, PA
13. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 563-570
14. Kong F.M., Ten Haken R., Eisbruch A., and Lawrence T.S. Non-small cell lung cancer therapy-related pulmonary toxicity: An update on radiation pneumonitis and fibrosis. Semin Oncol 32 (2005) S42-S54
15. Hernando M., Marks L., Bentel G., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
16. Segawa Y., Takigawa N., Kataoka M., et al. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys 39 (1997) 91-98
17. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
18. Graham M.V., Purdy J.A., Emami B., et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 33 (1995) 993-1000
19. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
20. Johnston C.J., Piedboeuf B., Rubin P., et al. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res 145 (1996) 762-767
21. Epperly M.W., Travis E.L., Sikora C., and Greenberger J.S. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: Modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis. Biol Blood Marrow Transplant 5 (1999) 204-214
22. Vujaskovic Z., Marks L.B., and Anscher M.S. The physical parameters and molecular events associated with radiation-induced lung toxicity. Sem Radiat Oncol 10 (2000) 296-307
23. Martin M., Lefaix J.-L., and Delanian S. TGFβ1 and radiation fibrosis: A master switch and a specific therapeutic target?. Int J radiat Oncol Biol Phys 47 (2000) 277-290
24. Barthelemy-Brichant N., Bosquee L., Cataldo D., et al. Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 58 (2004) 758-767
25. Fu X.L., Huang H., Bentel G., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 50 (2001) 899-890